New Strategic Initiatives Announced at Boston Biomedical Research Institute
Posted on: Tuesday, 20 June 2006, 18:00 CDT
WATERTOWN, Mass., June 20 /PRNewswire/ -- Boston Biomedical Research Institute (BBRI) has announced the formation of four new interdisciplinary programmatic initiatives that focus on disease-based basic research that build upon and bring together BBRI's unique strengths. Under the leadership of its Director, Dr. Charles Emerson, the groundwork for these programs began a year ago as part of a larger strategic plan initiative designed to address questions at the forefront of research that if answered, would ultimately further scientific discovery.
Scientists in each program area are beginning to develop specific plans for pilot projects. The Cancer Program will focus on generating therapies that prevent metastasis of lung, prostate, breast and pancreatic cancers, which are among the most deadly. The Cardiovascular Disease Program will search for new clues into the causes of heart failure, stroke and hypertension. The Regeneration, Development and Degenerative Disease Program will work with stem cells to deepen BBRI's expertise in Muscular Dystrophy and already established research programs in diabetes, aging and trauma. Finally, the Integrative Protein Biology Program will expand BBRI's core protein technology into systems biology enabling advancement in the areas of smooth muscle biology specifically looking into the cause and treatment of asthma.
Programmatic areas were introduced to BBRI Trustees and members of the Corporation in May by BBRI Faculty members Drs. Janice Dominov, Peter Erhardt, Eric Sundberg and Sarah Wilcox-Adelman and were welcomed with high enthusiasm and energy. BBRI Trustee and renowned cancer research pioneer at Children's Hospital Boston, Dr. Judah Folkman said, "BBRI has raised the bar in scientific excellence to an even higher level. The uniqueness of the Institute and its collaborative nature, combined with the originality of the proposed research projects, will enable BBRI to pursue cutting-edge basic and disease research."
Founded in 1968, Boston Biomedical Research Institute is a not-for-profit basic research institute dedicated to the understanding, treatment and prevention of a wide range of human diseases and conditions. For more information visit http://www.bbri.org/.
Boston Biomedical Research Institute
CONTACT: Terence McGowan of Boston Biomedical Research Institute,+1-617-658-7707, mcgowan@bbri.org
Web site: http://www.bbri.org/
Source: PRNewswire
Related Articles
- EPA Awards Lovelace Respiratory Research Institute $500,000 for Air Quality Research
- Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network
- Business Executive Amin J. Khoury Elected to Scripps Research Institute Board of Trustees
- Gulf of Maine Research Institutes Releases Study on Cost Estimates for Development of a Phased-in Groundfish Fishery Sector Monitoring Program
- Infectious Disease Research Institute Receives Grant From the Bill & Melinda Gates Foundation for Adjuvant Access and Development
- Metabolon Signs Collaboration With Army Medical Research Institute
- Aethlon Medical Signs Cooperative Research and Development Agreement With The U.S. Army Medical Research Institute of Infectious Diseases
- Florida Heart Research Institute Receives $100,000 Grant From The Blue Foundation
- Foundation for Clinical Research in Inflammatory Bowel Disease Launches MyIBD.Org
- Peregrine Pharmaceuticals and the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Sign Agreement for Anti-Viral Testing
 |
 |
User Comments (0)
RSS Feeds